Introduction {#s1}
============

Formation of organs during embryonic development requires a progressive restriction of lineage potential. This process, controlled by major signaling pathways, is achieved through changes in chromatin and in transcription factor (TF) networks: genes associated with pluripotency are progressively silenced by DNA methylation, histone modifications and chromatin compaction while key TFs selectively activate the expression of tissue specific genes ([@bib12]; [@bib52]). Therefore, knowing how the activity of TFs and epigenetic modification of the chromatin control organogenesis in vivo is essential to our understanding of both normal development and diseases. As a model system for organogenesis, we use the formation of the Kupffer's vesicle (KV), the first organ formed in the zebrafish embryo and that functions as the Left-Right Organizer (LRO). The KV is the fish homolog of the ventral node of the mouse, the *Xenopus* gastrocoel roof plate and the notochordal plate in rabbit. This organ is composed of \~50 monociliated cells organized as a hollow sphere with motile cilia facing its lumen. Rotation of these cilia generates a transient counterclockwise fluid flow that directs asymmetric activation of a conserved Nodal signaling pathway that guides asymmetric morphogenesis of developing organs ([@bib19]). This vesicle derives from a small population of \~20 precursor cells called the dorsal forerunner cells (DFCs), which are specified at the dorsal margin of the embryo at the onset of gastrulation in response to Nodal signaling ([@bib23]; [@bib50]). During gastrulation, DFCs arrange into a cluster that undergoes progressive compaction, followed by a mesenchymal to epithelial transition and organization of a single rosette. Following rosette formation, the center of this rosette opens to progressively give rise to the lumen of the differentiated KV. Finally, ciliogenesis takes place during the last phases of differentiation of DFCs into the KV. Altogether, the epithelial organization of KV progenitors associated with both luminogenesis and ciliogenesis leads to the formation of a functional LRO ([@bib43]).

The regulation of the organogenesis of the LRO, from the specification of its progenitors to a fully functional KV, is well described and involves the activity of Nodal, FGF, non-canonical Wnt, Notch and Hedgehog signaling pathways ([@bib43]). Conversely, a very limited number of TFs expressed in DFCs has been implicated in this process. Six genes have been identified so far, two Sox TFs: Sox32 and Sox17; two T-box TFs: Tbxta (also known as *notail*) and Tbx16 (also known as *spadetail*) and two TFs required for ciliogenesis: Foxj1a and Rfx2 ([@bib1]; [@bib5]; [@bib10]; [@bib38]; [@bib70]). It is highly unlikely that these six TFs are the only transcriptional regulators of the developmental program leading to the formation of the LRO. Indeed, in this study, we identified six additional transcription factors (TFs) and/or cofactors (TcoFs) crucial for the formation and function of the KV. Strikingly, although the Hippo signaling pathway was previously identified as a major regulator of tissue growth and organ size ([@bib36]; [@bib73]), we discovered that the DNA binding TFs (Tead1a and Tead3a), the TcoFs mediators of the Hippo signaling pathway (Yap and Taz) as well as the TcoFs Vgll4b and Vgll4l (two factors homologous to the mammalian Vgll4 that negatively regulates the activity of Yap and Taz) are upstream regulators of the formation and function of the LRO. These TFs and TcoFs (collectively named Hippo TFs/TcoFs thereafter in the text) control the function of signaling pathways involved in this process as well as the expression of genes essential to the formation and function of a ciliated epithelium with motile cilia. Finally, we identified that Vgll4l controls the expression in LRO progenitors of epigenetic factors, writers (the de novo DNA methyltransferases) and readers (Methyl-CpG binding domain proteins) of DNA methylation marks that we found essential for DFCs proliferation and survival as well as for the formation of motile cilia.

Results {#s2}
=======

Hippo TFs/TcoFs are required for the establishment of LR asymmetry {#s2-1}
------------------------------------------------------------------

To identify novel factors involved in the transcriptional regulation of the formation of the LRO we screened the zebrafish gene expression patterns database (<http://zfin.org/>) for TFs or TcoFs specifically expressed in the KV and/or in its progenitors. By this approach, we identified Vgll4l, a TcoF member of the Vestigial like four family, which is strongly expressed at gastrula stage in LRO progenitors ([Figure 1A](#fig1){ref-type="fig"}).

![Hippo TFs/TcoFs are essential for establishing the left-right asymmetry.\
(**A**) Whole-mount in situ hybridization for *vgll4l*, *yap*, *taz*, *vgll4b* and *tead3a* at gastrula and at the 6-somite stage. Vgll4l is expressed in DFCs at 60% (dorsal view), 80% (lateral view) and 90% epiboly (vegetal pole view) but is not expressed in the KV at the 6-somite stage (vegetal pole view). Yap and Taz are shown at 80% epiboly and at the 6-somite stage in vegetal pole view, Vgll4b at gastrula stage and Tead3a at the 6-somite stage in vegetal pole views. Tead1a that is constitutively expressed is not presented. White arrowheads point to DFCs, blue arrowheads point to the KV. (**B**) Cardiac jogging analyzed at 25 hr post fertilization (hpf). Graphs indicate the percentage of embryos with normal Left jog (L jog - yellow), Right jog (R jog -- dark blue) or no jog (light blue), visualized by in situ hybridization (top, h: heart) with *a myosin light chain 7 (myl7)* probed at 25 hpf in: wild-type (WT) embryos; embryos injected with standard (std) MO or with Vgll4l, Vgll4b, Yap, Taz, Yap and Taz, Tead1a or Tead3a MOs; embryos injected with ASO; rescue experiments of morphant phenotypes by injection of MO insensitive RNA; incubation with 2.5 µM of Verteporfin, a Yap inhibitor. For each experiment the name of gene, name and amount of MO and/or RNA injected are indicated on the left. For double Yap/Taz MO-KD, 4 ng Yap MOsp and 4 ng Taz MOsp2 have been injected. DFC 'name of the gene' MO indicates DFC-targeted knockdown experiment ([@bib64]). (MO + RNA) stands for rescue experiment of the indicated MO together with 100 ng of the corresponding, MO insensitive, mRNA. (**C**) Schematic of functional domains present in WT and in Vgll4l, Vgll4b, Yap, Taz and Tead3a mutants. nls: nuclear localization signal, PDZ: PDZ-binding motif, TA: transcription activation domain, TB: TEAD binding domain, TcoF-BD: transcription cofactor binding domain, TEA: DNA-binding TEA/ATTS domain, TDU: TONDU domain, WW: WW domain. Numbers indicate the position of the last amino-acid of each peptide. (**D**) Laterality defects of homozygous mutant embryos and of embryos homozygous mutant for Taz, heterozygous for Yap, analyzed as described in (**B**) for their cardiac jogging at 25 hpf. Numerical data for (**B**) and (**D**) are provided in [Figure 1---source data 1](#fig1sdata1){ref-type="supplementary-material"}.\
10.7554/eLife.45241.007Figure 1---source data 1.Numerical data for [Figure 1B, C, and D](#fig1){ref-type="fig"}.](elife-45241-fig1){#fig1}

Vestigial like family members are TcoFs known to function mainly through the interaction with TEA domain DNA-binding family of transcription factors (TEAD) ([@bib20]). TEADs are the DNA binding TFs to which the TcoFs that mediate the transcriptional outcome of the Hippo signaling pathway, Yap and Taz (also known as Wwtr1), bind to, to activate expression of their target genes. Interestingly, in various human cancer cell lines, Vgll4 was shown to negatively regulate the transcriptional outcome of Hippo signaling by competing with Yap and Taz for TEADs, therefore inhibiting their function ([@bib72]).

In addition to Yap and Taz, the zebrafish genome codes for three members of the Vgll4 family (Vgll4a, Vgll4b, Vgll4l) and four TEADs (Tead1a, Tead1b, Tead3a, Tead3b). However, only Vgll4l, Vgll4b, Yap, Taz, Tead1a and Tead3a are expressed in KV and/or KV progenitors ([Figure 1A](#fig1){ref-type="fig"}, [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). To investigate the function of these TFs and TcoFs in the formation of the LRO we performed general and/or DFC specific ([@bib5]) knockdown experiments using translation interfering and/or splice interfering morpholinos (MOs) and analyzed the effect of these loss of functions on the establishment of the LR asymmetry of the embryo. Looking at the direction of the heart jog at one day of development ([Figure 1B](#fig1){ref-type="fig"}) and at the expression of *lefty1* in dorsal diencephalon ([@bib60]) at 20 hr post fertilization ([Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}) we found that loss of function of each of these TFs or TcoFs strongly disrupts embryo laterality. Specificity of knockdown phenotypes was demonstrated by their reproducibility using different non overlapping MOs and in rescue experiments through injection of in vitro synthesized, MOs insensitive, mRNAs ([Figure 1B](#fig1){ref-type="fig"}). The implication of Yap in embryo laterality was further confirmed ([Figure 1B](#fig1){ref-type="fig"}) by incubating embryos in 2.5 µM of Verteporfin, a drug inducing Yap sequestration in the cytoplasm and promoting its degradation in the proteasome ([@bib65]).

To validate our observations obtained with MO knockdowns or drug treatment, we generated CRISPR-Cas9 mutants for *vgll4l*, *vgll4b*, *yap* and *taz.* For each gene, we identified insertions/deletions (INDELs) leading to a premature stop resulting in truncated proteins lacking essential functional domains ([Figure 1C](#fig1){ref-type="fig"}). For *tead3a,* a mutant lacking an essential splice site leading to a premature end of translation was obtained from the Zebrafish Mutation Project (ZMP) ([@bib37]). Whereas individual homozygous mutants embryos for Tead3a, Yap, Taz, Vgll4b and Vgll4l display normal morphology at late developmental stages ([Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}), analysis of their laterality fully confirmed the LR asymmetry defects observed in knockdown experiments ([Figure 1D](#fig1){ref-type="fig"}, [Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}).

In the mouse embryo, partial redundancy of Yap and Taz has been proposed to explain the weak phenotype observed in Taz mutants ([@bib46]; [@bib57]). In fish, whereas we observe mild laterality defects in *taz* morphants and mutants, these defects are much more severe in double Yap/Taz MO knockdowns ([Figure 1B](#fig1){ref-type="fig"}). In addition, lack of one copy of *yap* strongly increases the laterality defects observed in homozygous *taz* mutants (from 20% embryos with no heart jog or a right heart jog in single *taz* mutants to 55% for embryos homozygous for *taz* and heterozygous for *yap* - [Figure 1D](#fig1){ref-type="fig"}).

Altogether, the analysis of loss of function of Hippo TFs/TcoFs using a variety of approaches allowed us to uncover a novel and essential role for Hippo TFs/TcoFs in establishing LR asymmetry.

Hippo TFs/TcoFs are required for the formation of the LRO {#s2-2}
---------------------------------------------------------

We then investigated whether the laterality phenotypes observed for the loss of function of these TFs/TcoFs resulted from defects in the formation and/or function of the LRO. Because Yap and Taz are partially redundant, we analyzed their function conjointly, using double Yap/Taz loss of function. First, using in situ hybridization for *sox17*, an early DFC marker, we found that DFC clusters are present at early gastrula stage for every Hippo TF/TcoF mutant/morphant tested (not shown), strongly supporting that these factors are not required for the specification of LRO progenitors. Conversely, lack of their activity has a dramatic effect on the formation of the KV ([Figure 2A--D](#fig2){ref-type="fig"}, [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}) with a strong decrease of its size ([Figure 2E](#fig2){ref-type="fig"}). In contrast, gain of Yap function through injection of its in vitro synthesized mRNA in a DFC specific manner ([@bib22]; [@bib42]) results in an increase of the KV size associated with an increase in the number of KV cells ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}).

![Loss of function of Hippo TFs/TcoFs affects the formation of the Left-Right Organizer.\
(**A--D**) Illustration of the strong decrease in the size of the KV at the 12-somite stage in loss-of-function conditions shown in brightfield for (**A**) a control embryo (Ctrl) and for (**B**) a TEAD1a morphant embryo (Tead1a-MO) and by in situ hybridization using a *dand5* probe in (**C**) Ctrl and in (**D**) Vgll4b morphant embryo (Vgll4b-MO). (**E--H**) Effect of Vgll4l (V4l), Vgll4b (V4b), Tead1a (T1a), Tead3a (T3a) loss of function and of Yap/Taz (Y/T) double loss of function on: (**E**) the size of the KV (expressed as the area of the planar projection of its lumen), (**F**) the number of DFCs present at early gastrula stage (60% epiboly) and at the end of gastrulation (bud stage), (**G**) the proliferation of the DFCs measured as their mitotic index at 75% of epiboly, (**H**) the survival of DFCs measured as their apoptotic index at 90% epiboly. In all cases control (Ctrl) embryos were injected with 8 ng of Standard MO. Graph indicates the mean of each experiment, error bars indicate standard deviation and dots indicate the individual measurement for DFC groups or individual KV in control and loss of function conditions. Statistical significance between controls and the different loss-of-function conditions: two-tailed unpaired t-test. \*p≤0.05, \*\*p≤0.01, \*\*\*p≤0.001, \*\*\*\*p≤0.0001. ns: not significant. Numerical data for (**E--H**) and details of statistical analysis are provided in [Figure 2---source data 1](#fig2sdata1){ref-type="supplementary-material"}.\
10.7554/eLife.45241.012Figure 2---source data 1.Numerical data for [Figure 2E, F, G and H](#fig2){ref-type="fig"}.](elife-45241-fig2){#fig2}

During gastrulation, inWT embryos, DFCs proliferate, their number increasing from \~20 at the onset of gastrulation to \~50 in the differentiated KV. While the initial number of DFCs at early gastrula (60% epiboly) in embryos lacking Hippo TFs/TcoFs function is similar to control, we found a significant reduction in the DFC number at the end of gastrulation for each loss of function analyzed ([Figure 2F](#fig2){ref-type="fig"}). We then investigated whether the decrease in DFC number resulted from defects in cell proliferation and/or in cell survival. Measurement of the mitotic index at late gastrula stage revealed a moderate effect in Vgll4l, Yap/Taz and Tead1a knockdowns, while the mitotic index of the DFCs was not significantly affected in Vgll4b and Tead3a ([Figure 2G](#fig2){ref-type="fig"}). We also observed that cell survival, analyzed by measuring the apoptotic index of DFCs at 80% epiboly, was affected in Hippo TFs/TcoFs loss-of-function embryos ([Figure 2H](#fig2){ref-type="fig"}).

Finally, because motile cilia are essential to the function of the LRO, we looked for their presence and measured their length in embryos lacking activity of any of Hippo TFs/TcoFs. In all cases, we found a significant shortening of cilia ([Figure 3](#fig3){ref-type="fig"}) supporting that Hippo TFs/TcoFs are required for motile ciliogenesis.

![Loss of function of Hippo TFs/TcoFs leads to a reduction of the length of motile cilia of the KV.\
(**A--C**) Visualization of KV cilia at the 10-somite stage using an anti-acetylated tubulin antibody in (**A**) control embryos of the WT *Tg(dusp6:GFP)* line showing both KV cells (green) and cilia (red) or (**B**) only cilia. (**C**) cilia in Vgll4b morphant. Scale bar: 40 µm. (**D**) Length of KV cilia in Control (Ctrl) embryos and in Vgll4l, Vgll4b, Yap/Taz, Tead1a and Tead3a morphant embryos. Control (Ctrl) embryos were injected with 8 ng of Standard MO. Graph indicates the mean of cilia length, error bars the standard deviation. Statistical significance between controls and different loss-of-function conditions: two-tailed unpaired t-test. \*\*\*\*p≤0.0001. Numerical data and details of statistical analysis are provided in [Figure 3---source data 1](#fig3sdata1){ref-type="supplementary-material"}.\
10.7554/eLife.45241.014Figure 3---source data 1.Numerical data for [Figure 3D](#fig3){ref-type="fig"}.](elife-45241-fig3){#fig3}

There are contradictory reports on the role of Hippo signaling on ciliogenesis. In one study, Yap was described not to be involved in that process ([@bib39]), whereas another study linked Yap to the formation of non-motile cilia during zebrafish kidney development ([@bib29]). Our observations support the latter conclusion, implicating Yap in ciliogenesis and demonstrating that the canonical Hippo pathway is required for proper organization of motile cilia.

The TcoFs Yap/Taz and Vgll4l control the transcriptome of LRO progenitors {#s2-3}
-------------------------------------------------------------------------

Because Vgll4l and Yap/Taz are TcoFs, they are expected to function by regulating gene expression. In a first experiment, we examined the consequences of their loss of function by MO knockdown on the expression of the 78 DFC specific genes we previously identified in high throughput in situ hybridization screens (<http://zfin.org/>, gene expression section). Expression of 30% of tested candidates (24/78) was either strongly decreased or completely absent in Vgll4l depleted DFCs ([Figure 4](#fig4){ref-type="fig"}).

![DFC specific genes downregulated in Vgll4l loss of function.\
Whole-mount in situ hybridization for genes that are expressed in DFCs at 70--90% epiboly in control (Ctrl) embryos and that are strongly downregulated in Vgll4l MO knockdown. Embryos are in dorsal view, animal pole to the top (**A--L**), in vegetal pole view dorsal to the right (**M--W**) and in lateral view anterior to the top dorsal to the right (**X**). Name of the genes probed is indicated in between control (top) and Vgll4l loss of function embryos (bottom).](elife-45241-fig4){#fig4}

Remarkably, 1/3 (8/24) of these genes are known to be required for the formation of the KV. They are involved in cilium assembly (*cdc14aa*, *daw1, dnaaf4*, *ttc25*), KV lumen expansion (*cftr*, *cldn5a*), proton transport (*atp6ap1b*) that has been shown to mediate DFC proliferation ([@bib26]), DNA methylation (*dnmt3bb.1*) or belong to the Nodal signaling pathway (*ndr1*). Similarly, we found that DFCs depleted for Yap/Taz display a clear decrease in expression for *cdc14aa*, *tnfrsf21, dnaaf4*, *cftr* or *ndr1* (not shown). Therefore, in addition to their known function in regulating cell proliferation and survival, Vgll4l and Yap/Taz regulate, directly or indirectly, the expression of genes that are essential for a variety of processes involved in the formation and function of the KV.

We investigated the tissue specificity of Vgll4l and Yap activity by performing DFC specific MO knockdowns for a subset of these 24 probes ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). In all cases we observed a strong decrease of the expression of these genes in the progenitors of the LRO. This shows that the regulation of the expression of DFC specific genes by Yap and Vgll4l we observed is not a secondary consequence of a global loss of function affecting the whole embryo from the beginning of development but results from the activity of these TcoFs in the DFCs.

We extended this study by establishing the transcriptome of LRO progenitors at late gastrula stage in Vgll4l or in Yap/Taz morphant embryos from the line *Tg(sox17:GFP)^S870^* ([@bib54]), which fluorescently labels DFCs. For each condition (control, Vgll4l or Yap/Taz loss of function), four DFC clusters were isolated and their RNA sequenced. Principal Component Analysis (PCA) was performed on transcriptome data of the four replicates for each condition ([Figure 5A](#fig5){ref-type="fig"}) and reveals that experimental replicates were highly reproducible and strongly clustered. Each experimental condition segregated in distinct groups pointing out that DFCs of control embryos and of embryos lacking Vgll4l or Yap/Taz have clearly distinct transcriptomes.

![Transcriptome analysis of DFCs lacking Vgll4l or Yap/Taz function.\
(**A**) Principal component analysis (PCA) of DFC transcriptomes for Vgll4l morphants (red), Yap/Taz double morphants (blue) and control (green) showing that the four experimental replicates were highly reproducible and strongly clustered while each experimental condition segregated in distinct groups. (**B**) Venn diagram illustrating overlaps of differentially expressed genes (DEGs) between groups of DFCs lacking activity of Vgll4l (red line) or Yap/Taz (blue line). Downregulated genes (green), upregulated genes (orange). (**C**) Significant DEGs for Vgll4l (top, red) and for Yap/Taz (bottom, blue) were analyzed for selected biological processes. Bars represent the percentage of associated genes assigned to an unique GO term with the absolute number of associated genes located at the end of the bars (p-value corrected with Benjamini-Hochberg : \*\*p≤0.01, \*\*\*p≤0.001, \*\*\*\*p≤0.0001). (**D**) Heatmap of DEGs whose loss of function is associated with DFCs and/or KV phenotypes. (**E**) Examples of genes downregulated in Vgll4l or in Yap/Taz depleted embryos: *dnaaf4* which is required for cilia movement ([@bib58]), *atp6ap1b* known to mediate DFC proliferation ([@bib26]); *cftr* that controls KV lumen expansion ([@bib48]); *cdc14aa* that contributes to ciliogenesis ([@bib17]). *ttc25* that is critical for cilia formation and function ([@bib69]) is downregulated in both Vgll4l and Yap/Taz loss of function but is not a DEG for Yap/Taz. Finally *daw1* that is essential for dynein assembly and ciliary motility ([@bib25]) is downregulated only in Vgll4l loss of function. Graph bars indicate the mean expression expressed in normalized counts, the error bars the standard deviation and the dots, the value of each biological replicate. Statistical significance between controls and the different loss of function conditions: two-tailed unpaired t-test. \*\*\*\*p≤0.0001. ns: not significant (either p\>0.05 and/or \|log2FoldChange\| \< 1). Numerical data for (**E**) are available in [Supplementary file 1](#supp1){ref-type="supplementary-material"}.](elife-45241-fig5){#fig5}

We found 9215 differentially expressed genes (DEGs: genes with normalized counts ≥ 1; \|log2FoldChange\| ≥ 1; Benjamini-Hochberg - False Discovery Rate - adjusted p-value\<0.05) in DFCs of embryos depleted in Vgll4l and 7,925 DEGs in DFCs of embryos lacking both Yap and Taz activities ([Supplementary file 1](#supp1){ref-type="supplementary-material"}). As a quality control of RNA sequencing, we confirmed that the expression of all the 24 genes found strongly decreased in Vgll4l loss of function in our in situ hybridization analysis ([Figure 4](#fig4){ref-type="fig"}) was also significantly downregulated in the transcriptome of Vgll4l depleted DFCs ([Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}).

Analysis of the overlapping sets of DEGs for Vgll4l and Yap/Taz loss of function (6423 genes - [Figure 5B](#fig5){ref-type="fig"}) revealed that 84% (5394/6423) of them are regulated similarly in DFCs (either downregulated or upregulated) by Vgll4l and by Yap/Taz while only 16% (1029/6423) are regulated in opposing ways (upregulated in loss of function of Vgll4l while downregulated in Yap/Taz or vice-versa). This is a surprising observation as Vgll4 in other model systems is thought to act antagonistically to Yap/Taz by competition for the binding to TEADs ([@bib36]). Because the DEGs identified in the transcriptome analysis include both direct and indirect target genes, we examined the effect of Vgll4l and of Yap/Taz loss of function on the expression of zebrafish homologues of direct target genes of Yap in mammals. We found 318 homologues for 380 Yap direct target genes described in mammals ([@bib41]; [@bib67]; [@bib71]) present within the zebrafish genome (GRCz10). Amongst them 143 were DEGs for both Vgll4l and Yap/Taz. Analysis of the transcriptome data revealed ([Supplementary file 2](#supp2){ref-type="supplementary-material"}) that 82.5% of these genes (118/143) are regulated similarly by Vgll4l and Yap/Taz (61 downregulated and 57 upregulated in morphant DFCs) while only 17.5% (25/143) are regulated in opposite ways. It is very likely that most of the genes that are direct targets of Yap in mammals will also be direct targets of Yap in zebrafish. Therefore, the similar regulation of these genes by Vgll4l and by Yap/Taz is a strong evidence against a role of Vgll4l as a Yap antagonist during formation of the LRO in zebrafish.

To identify the biological function of DEGs for Vgll4l and Yap/Taz, we determined the functional categories of each gene by querying the Gene Ontology (GO) database ([@bib6]; [@bib59]). Functional grouping of the GO terms based on GO hierarchy revealed that amongst the most prominent groups are those associated with the formation and function of the LRO: determination of LR symmetry, cilium movement, cilium organization and epithelium development ([Figure 5C](#fig5){ref-type="fig"}). In addition, mitotic cell cycle process was a GO term found for Yap/Taz while Vgll4l was associated with the GO term covalent chromatin modification, uncovering a role for this TcoF in the regulation of the expression of epigenetic factors.

Amongst the 166 genes whose loss of function has been described resulting into phenotypic defects in DFCs or in KV (<http://zfin.org/>, phenotype section), we found 134 genes expressed in DFCs at late gastrula stage. Remarkably, 62% (83/134) and 50% (67/134) of these genes are respectively downregulated in loss of function of Vgll4l and Yap/Taz ([Figure 5D](#fig5){ref-type="fig"}, [Supplementary file 3](#supp3){ref-type="supplementary-material"}). This includes 75% (46/61) of genes involved in motile ciliogenesis and associated with defects of the KV function for Vgll4l depleted DFCs and 52% (32/61) for Yap/Taz loss of function ([Supplementary file 4](#supp4){ref-type="supplementary-material"}). Phenotypic analysis already revealed that these TcoFs are essential to proper formation of KV motile cilia ([Figure 3](#fig3){ref-type="fig"}). Altogether, our transcriptome analysis further reinforced the conclusion that these factors play a major role in the regulation of motile ciliogenesis during the formation of the LRO.

Yap/Taz and Vgll4l regulate the activity of signaling pathways involved in LRO formation {#s2-4}
----------------------------------------------------------------------------------------

The molecular and cellular processes leading to the formation of a functional LRO are known to be regulated by major signaling pathways including Nodal, FGF, non-canonical Wnt and Notch (reviewed in [@bib43]). We investigated the impact of Vgll4l and Yap/Taz on the expression of essential components (ligands, receptors, signal transductors, regulators) of these different pathways in DFCs at late gastrula stage. We found a strong downregulation of *nodal related 1* (*ndr1*) expression in both Vgll4l ([Figures 4C](#fig4){ref-type="fig"} and [6A](#fig6){ref-type="fig"}) and Yap/Taz ([Figure 6A](#fig6){ref-type="fig"}) loss of function. In Vgll4l, this loss of Ndr1 transcripts is associated with a strong decrease of the expression of *smad2a*, a R-Smad known to transduce Nodal signaling and with a strong upregulation of the expression of two Nodal feedback antagonists, *lefty1* (*lft1)* and *lefty2* (*lft2*) ([@bib2]). Both the decrease in Smad2a transcripts and the upregulation of Lft1 and Lft2 expression may disrupt the Nodal positive autoregulatory loop that is essential for the maintenance of *ndr1* transcription. In Yap/Taz loss of function, the strong decrease in *ndr1* expression is associated with a decrease in Smad3a transcripts, another R-Smad transducing Nodal signaling, but we did not observe an upregulation of Lft1 or Lft2 expression ([Figure 6A](#fig6){ref-type="fig"}).

![Regulation by Vgll4l or by Yap/Taz of critical genes from major signaling pathways controlling the formation of the KV.\
(**A**) Strong downregulation of *nodal related 1* (*ndr1*) expression in Vgll4l and Yap/Taz morphants. For Vgll4l, loss of Ndr1 transcripts is associated with a strong decrease of the expression of *smad2a*, a R-smad known to transduce Nodal signaling, as well as to a strong upregulation of the expression of Nodal feedback antagonists, *lefty1* (*lft1)* and *lefty2* (*lft2*). In Yap/Taz loss of function, the strong decrease in *ndr1* expression is associated with a decrease in expression of *smad3a*, another R-Smad transducing Nodal signaling, but not with an upregulation of *ltf1/2*. (**B**) There is a strong downregulation of expression of ligand (Wnt11) and receptors (Fzd8a and Fzd10 for Vgll4l, Fzd8a for Yap/Taz) of the non-canonical Wnt pathway. (**C**) Expression of ligands (Fgf8a and Fgf1a for Vgll4l; Fgf1a for Yap/Taz) and receptor (Fgfr1a) of the FGF signaling pathway is strongly downregulated in both Vgll4l and Yap/Taz loss-of-function conditions. Transcripts of the positive regulator (Cnpy1) are strongly decreased in Vgll4l loss of function. (**D**) The expression of ligands (Dla, Jag2b) and receptors (Notch1a, Notch1b and Notch3) of the Notch pathway is downregulated in DFCs lacking either Vgll4l or Yap/Taz. Bar graphs depict the mean expression of genes in DFCs of control (gray), Vgll4l (red) and Yap/Taz (blue) loss of function expressed as normalized counts with error bars indicating standard deviation. Dots indicate the individual value of each biological replicate (n = 4). Statistical significance between controls and the different loss-of-function conditions: two-tailed unpaired t-test. \*p≤0.05, \*\*p≤0.01, \*\*\*p≤0.001, \*\*\*\*p≤0.0001. ns: not significant (either p\>0.05 or \|log2FoldChange\| \< 1). Numerical data are available in [Supplementary file 1](#supp1){ref-type="supplementary-material"}.](elife-45241-fig6){#fig6}

In addition to Nodal, the non-canonical Wnt, the FGF and the Notch pathways are also affected. We observed a strong downregulation of expression of ligand (Wnt11) and receptors (Fzd8a, Fzd10 for Vgll4l, Fzd10 for Yap/Taz) of the non-canonical Wnt pathway ([Figure 6B](#fig6){ref-type="fig"}). Expression of ligands (Fgf8a and Fgf1a for Vgll4l; Fgf1a for Yap/Taz) of the FGF signaling pathway is downregulated in both Vgll4l and Yap/Taz loss-of-function conditions and the amount of transcripts of the Fgf receptor, Fgfr1a, and of the positive Fgf feedback regulator, Cnpy1, is strongly decreased in DFCs lacking Vgll4l ([Figure 6C](#fig6){ref-type="fig"}). As well the expression of ligands (Dla, Jag2b) and receptors (Notch1a, Notch1b and Notch3) of the Notch signaling pathway ([Figure 6D](#fig6){ref-type="fig"}) is downregulated in DFCs lacking either Vgll4l or Yap/Taz. Altogether, these observations provide evidence that Vgll4l and Yap/Taz are essential upstream regulators of the major signaling pathways controlling the formation of the LRO.

Yap/Taz and Vgll4l control expression of TFs known to be required for LRO formation {#s2-5}
-----------------------------------------------------------------------------------

The precise temporal order by which TFs selectively activate gene expression during development is critical to ensure proper lineage commitment, cell fate determination, and ultimately organogenesis.So far, only a small number of TFs has been shown to be necessary for the formation of the LRO, either for the specification of its progenitors \[Dharma ([@bib24]), Sox32 ([@bib23]), Sox17 ([@bib1])\] or for the formation and function of the KV \[FoxJ1a ([@bib70]), Tbx16 ([@bib4]), Tbxta ([@bib4]) and Rfx2 ([@bib10])\]. We investigated the impact of loss of function of Vgll4l or Yap/Taz on the expression in LRO progenitors of these TFs. Because *dharma* is not expressed in DFCs at gastrula stage it is therefore not regulated in these cells by Vgll4l or Yap/Taz. However, transcripts of *sox32*, *sox17*, *tbxta*, *tbx16*, *foxj1a* and *rfx2* are expressed in DFCs during gastrulation and we found they are all significantly downregulated in Vgll4l and Yap/Taz loss of function ([Figure 7](#fig7){ref-type="fig"}). These observations strongly support that Vgll4l and Yap/Taz act upstream of the TFs known to be essential to the formation of the LRO and are involved in the regulation of their expression.

![Vgll4l and Yap/Taz regulate expression of TFs required for KV formation.\
Transcripts of Sox32, Sox17, Tbxta, Tbx16, Foxj1a and Rfx2 are expressed in DFCs and are all significantly downregulated in Vgll4l and Yap/Taz morphants. The bar graphs depict the mean expression of genes in DFCs of control (gray), Vgll4l (red) and Yap/Taz (blue) loss of function expressed as normalized counts with error bars indicating standard deviation. Dots indicate the individual value of each biological replicate (n = 4). Statistical significance between controls and loss of function conditions: two-tailed unpaired t-test. \*p≤0.05, \*\*p≤0.01, \*\*\*p≤0.001, \*\*\*\*p≤0.0001. ns: not significant (p\>0.05 and/or \|log2 fold change\| \< 1). Numerical data are available in [Supplementary file 1](#supp1){ref-type="supplementary-material"}.](elife-45241-fig7){#fig7}

Vgll4l regulates expression of writers and readers of DNA methylation marks in LRO progenitors {#s2-6}
----------------------------------------------------------------------------------------------

Lineage commitment, cell fate determination and ultimately organogenesis are also regulated by epigenetic mechanisms. Transcriptome analysis revealed that depletion of Vgll4l affects expression of genes involved in covalent chromatin modification ([Figures 5C](#fig5){ref-type="fig"} and [8](#fig8){ref-type="fig"}). Indeed, in DFCs, Vgll4l loss of function leads to a strong downregulation of the expression of genes coding for writers of the DNA methylation marks: the de novo DNA methyltransferases Dnmt3ba, Dnmt3bb.1, Dnmt3bb.2 ([@bib15]) ([Figures 4Q--R](#fig4){ref-type="fig"} and [8](#fig8){ref-type="fig"}) and the maintenance DNA methyltransferase Dnmt1 ([@bib47]) ([Figure 8](#fig8){ref-type="fig"}). In addition we found that Vgll4l also regulates the expression of the readers of DNA methylation marks, the Methyl-CpG-Binding Domain proteins: Mbd1b, Mbd2, Mbd3a ([Figure 8](#fig8){ref-type="fig"}), Mbd3b ([Figures 4S](#fig4){ref-type="fig"}, [8](#fig8){ref-type="fig"}) (note that while in mammals the methyl binding domain of MBD3 harbors critical mutations - K30H and Y34F - preventing it to bind to methylated DNA ([@bib53]), the methyl binding domain of Mbd3 in lower vertebrates retains the K30 and Y34 amino acids and binds to methylated DNA ([@bib11]) and Mbd6 ([Figure 8](#fig8){ref-type="fig"}). The other Dnmts and Mbds encoded by the zebrafish genome are either not expressed or expressed at low level in DFCs at late gastrula stage ([Supplementary file 1](#supp1){ref-type="supplementary-material"}).

![Vgll4l regulates expression of epigenetic factors writers and readers of DNA methylation marks.\
The bar graphs depict the mean expression of genes in DFCs of control (gray), Vgll4l (red) loss of function expressed as normalized counts with error bars indicating standard deviation. Dots indicate the individual value of each biological replicate (n = 4). Statistical significance between controls and loss of function conditions: two-tailed unpaired t-test. \*p≤0.05, \*\*p≤0.01, \*\*\*p≤0.001, \*\*\*\*p≤0.0001. ns: not significant (p\>0.05 and/or \|log2 fold change\| \< 1). Numerical data are available in [Supplementary file 1](#supp1){ref-type="supplementary-material"}.](elife-45241-fig8){#fig8}

We investigated the possible role of these writers and readers of DNA methylation marks in the establishment of LR asymmetry by examining cardiac jogging defects in loss-of-function conditions ([Figure 9A](#fig9){ref-type="fig"}). Depletion of the de novo DNA methyltransferase, Dnmt3bb.1 has been previously shown to affect the establishment of the LR asymmetry ([@bib66]). We confirmed this observation with a TALEN induced mutant that affects only the catalytic site of Dnmt3bb.1. Similarly, we found that loss of function of other de novo Dnmts expressed in DFCs (Dnmt3bb.2 and Dnmt3ba) or depletion of the readers of the DNA methylation marks, Mbd3a and Mbd3b also affect the establishment of the LR asymmetry ([Figure 9A](#fig9){ref-type="fig"}).

![Similarity between phenotypes of Dnmt3bs, Mbd3s and Vgll4l loss of function in DFCs.\
(**A**) Loss of function of writers (*dnmt3s*) and readers (*mbds*) of DNA methylation marks strongly disrupt embryo laterality, analyzed by examining cardiac jogging at 25 hpf. Graphs indicate the percentage of embryos with normal Left jog (L jog - yellow), Right jog (R jog -- dark blue) or no jog (light blue), at 25 hpf in control embryos (injected with 8 ng Standard - Std - MO), MO KDs (8 ng each MO) or in homozygous mutant embryos (-/-). (**B--F**) Phenotype analysis of LRO defects in morphants. (**B**) Size of the KV expressed in surface area of the planar projection of its lumen, (**C**) number of DFCs at the end of gastrulation, (**D**) Mitotic index at 80% epiboly, (**E**) Apoptotic index at gastrulation and (**F**) Length of KV cilia in : control (Ctrl) embryos (gray), Vgll4l (red), Dnmt3bb.1 (green) or Mbd3b (blue) MO knockdowns. Statistical significance between controls and loss of function conditions: two-tailed unpaired t-test. \*p≤0.05, \*\*p≤0.01, \*\*\*p≤0.001, \*\*\*\*p≤0.0001. Numerical data (**A--H**) and details of statistical analysis for (**B--F**) are provided in [Figure 9---source data 1](#fig9sdata1){ref-type="supplementary-material"}. (**G**) Injection of 100 ng of in vitro synthesized Dnmt3bb.1 RNA partially rescues laterality defects of Vgll4l morphants (8 ng Vgll4l MO), scored on cardiac jogging at 25 hpf.\
10.7554/eLife.45241.023Figure 9---source data 1.Numerical data for [Figure 9A, B, C, D, E, F and G](#fig9){ref-type="fig"}.](elife-45241-fig9){#fig9}

Phenotypic analyses of KV formation in embryos depleted for one de novo Dnmt (Dnmt3bb.1) or for one Methyl-CpG-Binding Domain protein (Mbd3b) reveals striking similarities with Vgll4l loss-of-function phenotype: reduction of KV size ([Figure 9B](#fig9){ref-type="fig"}), decreased number of DFCs at late gastrulation ([Figure 9C](#fig9){ref-type="fig"}) associated with a moderate decrease of DFC mitotic index ([Figure 9D](#fig9){ref-type="fig"}), an increased apoptotic index ([Figure 9E](#fig9){ref-type="fig"}) as well as a significant reduction in length of KV motile cilia ([Figure 9F](#fig9){ref-type="fig"}).

These observations strongly support that defects in KV organogenesis observed in Vgll4l loss of function may result, at least in part, from the decreased expression of Dnmt3bs and Mbd3s in DFCs. In strong agreement with this hypothesis, we found that laterality defects of Vgll4l loss of function can be partially rescued by gain of function of Dnmt3bb.1 ([Figure 9G](#fig9){ref-type="fig"}).

Because Vgll4l is necessary for Dnmt3bs expression we predict that its loss of function should impact DNA methylation of KV progenitors. To test this hypothesis we quantified DNA methylation in DFCs through an antibody-based detection of global nuclear DNA methylation using an anti 5-methylcytosine antibody ([@bib7]). We found a significant decrease in DNA methylation of DFC nuclei in both Vgll4l morphants and in homozygous *vgll4l* mutants ([Figure 10](#fig10){ref-type="fig"}). This shows that Vgll4l regulates epigenetic programming in LRO progenitors by controlling in the DFCs the expression of epigenetic modifying enzymes.

![Effect of Vgll4l and Dnmt3bb.1 loss of function on DNA methylation in DFC nuclei.\
(**A--F**) Immunolabeling of DFC nuclei of embryos of the *Tg(Sox17:GFP)* strain with antibodies to five methyl Cytosine (5meC) in (**A--C**) WT and (**D--F**) *vgll4l* homozygous mutant. Dotted lines delimit the DFC clusters. (**G**) Quantification of DNA methylation measured by immunofluorescence intensity. The values on the graph correspond to the mean of 5meC fluorescence intensity per nuclei (FI/nuclei) quantified with the ImageJ software on all nuclei of DFC clusters in morphants for Vgll4l and Dnmt3bb.1 and in embryos from a cross between two heterozygous Vgll4l mutants that have been individually genotyped after measurement of FI/nuclei of their DFCs. Fluorescence intensity per nuclei is expressed in relative units (R.U.). Statistical significance between controls (standard MO or *vgll4l* +/+) and loss of function conditions: two-tailed unpaired t-test. ns, not significant (p\>0.05), \*p≤0.05, \*\*p≤0.01, \*\*\*p≤0.001, \*\*\*\*p≤0.0001. Numerical data and details of statistical analysis for (**G**) are provided in [Figure 10---source data 1](#fig10sdata1){ref-type="supplementary-material"}.\
10.7554/eLife.45241.025Figure 10---source data 1.Numerical data for [Figure 10G](#fig10){ref-type="fig"}.](elife-45241-fig10){#fig10}

Discussion {#s3}
==========

Formation of organs during embryonic development requires both epigenetic modification that restricts lineage potential and the activation of tissue specific genes during the process of cell differentiation. Using the formation of the first functional organ of the zebrafish, the KV, as a model system we addressed the question of the transcriptional regulation of organ formation. Because this transient organ acting as the LRO in fish is very simple and is functional in just a few hours and from a well characterized population of progenitors, this model is particularly suitable to characterize how TFs and epigenetic modification control the differentiation of a ciliated epithelium during organogenesis. Since its description by Kupffer in 1867 ([@bib68]) the KV has been studied in much details at the cellular and molecular levels. Genetic screens have identified 166 genes to be required for its formation and/or function (<http://zfin.org/>, phenotypes, Kupffer's vesicle). Surprisingly only 6 TFs: Rfx2, Foxj1a, Sox17, Sox32, Tbxta, Tbx16 have been reported to be necessary to the formation and function of the LRO. In the current study we identified six additional TFs and TcoFs required for this process. Our functional analyzes (morpholino knockdowns, drug treatment and Crispr-Cas9 mutants) reveal that the TcoFs known to mediate the transcriptional outcome of the Hippo signaling pathway (Yap and Taz), the DNA binding transcription factors they associate to (Tead1a and Tead3a) as well as Vgll4b and Vgll4l, two homologs of the mammalian Vgll4 that has been shown to negatively regulate Yap and Taz transcriptional activity, act as upstream regulators controlling the formation of the LRO of the zebrafish embryo. Each of these six genes is therefore essential for the establishment of the LR asymmetry of the embryo. Hippo TFs/TcoFs are not involved in the specification of LRO progenitors but are crucial for the regulation of their number at the end of gastrulation. However, while there is an effect on proliferation and viability of DFCs, most of the KV progenitors survived past gastrulation. The impact of Yap/Taz, Vgll4s and TEADs on the formation of the KV is not restricted to the final number of cells available for the formation of the vesicle but they also control the formation of the epithelium of the KV as well as cilia organization and motility.

Based on previous studies, mainly performed in pathological conditions, Vgll4 family members have been proposed to compete with Yap/Taz for TEADs, therefore inhibiting Yap/Taz function ([@bib35]; [@bib72]). However, during the process of differentiation of LRO progenitors, we found that Vgll4b and Vgll4l act similarly to Yap and Taz, regulating the number of DFCs and controlling motile ciliogenesis. This strongly suggests that Vgll4s do not act as antagonists of Yap/Taz activity during formation of the LRO but that they rather function in the same or in parallel pathways.

Investigation of the impact of loss of function for Yap/Taz and for Vgll4l on the transcriptional network of the precursors of the LRO (both using a candidate gene approach and transcriptome analyzes) reveals that these transcription cofactors control expression of a large fraction (50% and 62% respectively) of the genes previously shown to be necessary for the formation and/or function of the LRO. This includes most of the genes required in the LRO for motile ciliogenesis (75% of them for Vgll4l, 52% for Yap/Taz). To the best of our knowledge, our study describes the first transcriptional networks during the formation of a ciliated epithelium. We also found that Hippo TFs/TcoFs regulate essential factors of major signaling pathways that have been shown to regulate KV precursor cell behaviors (clustering, collective migration, rosette formation, luminogenesis) during gastrulation and early somitogenesis until the formation of the fully functional LRO \[reviewed in [@bib43]\].

Amongst the genes whose expression requires Yap/Taz and Vgll4l activities are essential factors (ligands, receptors, positive or negative regulators) of the major signaling pathways (Nodal, FGF, non-canonical Wnt and Notch/Delta) known to be critical to the formation of the LRO. This observation therefore places Yap/Taz and Vgll4l upstream of these signaling pathways and strongly supports that these TcoFs are master regulators of the formation and function of the LRO.

The activity of the Nodal signaling pathway has been shown to be modulated through DNA methylation of the regulatory sequences of the Nodal antagonist Lefty ([@bib18]) ([@bib66]). In WT embryos, *lefty* genes are not expressed in the precursors of the LRO. However, our transcriptome analysis revealed expression of *lft1* and *lft2* in DFCs of Vgll4l morphant embryos associated with a strong reduction of *ndr1* expression ([Figure 6](#fig6){ref-type="fig"}). In these Vgll4l depleted embryos, we also found strong downregulation of genes coding for the 'de novo' DNA methyltransferases that establish the initial DNA methylation pattern ([Figure 8](#fig8){ref-type="fig"}). Expression of Nodal is also strongly downregulated in embryos devoid of Yap/Taz activity. However, expression of *lft1* and *lft2* is not observed in the DFCs of Yap/Taz morphant embryos and genes coding for Dnmts were not downregulated in Yap/Taz loss of function. These observations show (1) that *ndr1* expression and activity are controlled in the DFCs by Vgll4l and Yap/Taz and (2) strongly suggest that distinct mechanisms are used by Vgll4l and Yap/Taz to regulate Nodal signaling in the DFCs, with Vgll4l repressing *lft1* and *lft2* expression likely through a positive control of the expression of de novo DNA methyltransferases in the progenitors of the LRO. The effect of Vgll4l loss of function on DNA methylation of DFC nuclei strongly support this interpretation.

The role of DNA methylation in chromatin modifications associated with cell differentiation has been extensively analyzed. However, the upstream regulation of this process is far less understood. Our study reveals that one transcription cofactor, Vgll4l, is required in the progenitors of the LRO for the expression of epigenetic factors, writers (the de novo DNA methyltransferase 3) and readers (Methyl-CpG binding domain proteins) of DNA methylation marks. This identifies another level of regulation of epigenesis during embryonic development through the tissue specific control of the expression of major epigenetic actors. The demonstration that Vgll4l regulates epigenetics in a temporal and spatial manner by affecting the expression of some of its major actors opens a new field of exploration for the understanding of the regulation of gene expression during cell differentiation.

Materials and methods {#s4}
=====================

Zebrafish line and husbandry {#s4-1}
----------------------------

Zebrafish lines used in this study are the *AB/Tü* WT line, *Tg(sox17:GFP)^S870^* ([@bib16]) and *Tg(dusp6:GFP)^pt19^* ([@bib63]). *vgll4l^va1^* (an allele carrying a deletion of 7 nucleotides in the second exon resulting in a frame shift after amino-acid 36), *vgll4b^va2^* (an allele carrying an INDEL - ∆4,+6 - resulting in a frame shift after amino-acid 109), *yap1^va3^* (an allele of yap carrying a deletion of 8 nucleotides resulting in a frame shift after amino-acid 124), *wwtr1^va4^* (an allele of taz carrying a deletion of 4 nucleotides resulting in a frame shift after amino-acid 85), *dnmt3bb.1^mk24^* (an allele carrying a deletion of 6 nucleotides removing Ser 612 and Pro 613, two amino-acids of the catalytic site), *dnmt3bb.2^mk23^* (an allele carrying an InDel - ∆5+13 -- resulting in a frame shift after amino-acid 1237 and that lack the catalytic site) and dnmt3bamk26 (an allele carrying a 12 nucleotides deletion in the catalytic domain). Position and sequence of the different mutations are presented in [Supplementary files 6](#supp6){ref-type="supplementary-material"}--[9](#supp9){ref-type="supplementary-material"}.

This study was carried out in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals and all steps were taken to minimize animal discomfort. The University of Virginia Institutional Animal Care and Use Committee approved all protocols.

In situ hybridization {#s4-2}
---------------------

In situ hybridization on whole-mount embryos have been performed as described in [@bib62]; [@bib61]. Conditions for the synthesis of antisense RNA probes for the following cDNA clones : *abcc6a* ([@bib40]) ; *atp6ap1b* (MGC:103523) ; *cdc14aa* (MGC:63654) ; *cldn5a* (MGC:85723) ; *daw1* (IMAGE:6904039) ; *dhrs13a.1* (cb464) ; *dnaaf4* (MGC:77853) ; *dnmt3bb.1* (cb633) ; *mbd3a* (IMAGE:7139207), *mbd3b* (cb99) ; *nme5* (MGC:92812) ; *quo* (cb9) ; *rasgef1ba* (MGC:66487) ; *rassf7b* (cb262) ; *si:ch73-364h19* (cb911) ; *slc35d1a* (IMAGE:7156746) ; *sox17* (MGC:91776) ; *sypl2b* (IMAGE:7136581) ; *tead1a* (MGC:63696) ; *tead3a* (CB882) ; *tekt1* (MGC :101797) ; *ttc25* (MGC:56362) ; *vgll4l* (cb747) and *yap1* (cb194) are available at <http://zfin.org/> in the gene expression section.

The cDNAs of *ndr1* ([@bib3]) and *dand5* were inserted in the pBS-IISK+ vector, the cDNA of *cftr* (MGC:198381) was inserted in the pCR-XL-TOPO reverse vector as well as of *vgll4b* and *wwtr1* (*taz*) that were inserted in pCR2.1 TOPO vectors, PCR amplified using M13 forward and reverse primers and their antisense RNA synthesized using the T7 RNA polymerase. cDNA for dnmt3bb.2 inserted in pCR2.1 TOPO vector was PCR amplified using M13 forward and 5'- GGATCCATTAACCCTCACTAAAGGGAAGACAGGAAACAGCTATGACC-3' primers and its RNA synthesized using the T3 RNA polymerase. cDNAs for *cfap45* (MGC: 158569), *tnfrsf21* (IMAGE:2602431) inserted in pME18S-FL3 vector were PCR amplified using 5\'-TGTACGGAAGTGTTACTTCTGCTC-3\' and 5\'-GGATCCATTAACCCTCACTAAAGGGAAGGCCGCGACCTGCAGCTC-3\' primers and the antisense RNAs synthesized using the T3 RNA polymerase.

Representative images were acquired using a coolsnap camera on a Leica macroscope.

Morpholino knockdowns {#s4-3}
---------------------

Morpholinos (Gene Tools) were resuspended in sterile water as a 4 mM stock solution and diluted in 0.2% Phenol Red and 0.1M KCl before use to the appropriate concentration. Embryos were dechorionated at the one-cell stage using Pronase E and injected with 1 nl of morpholino solution, using an Eppendorf 5426 microinjector.

For knockdowns in the whole embryo, morpholino solutions were injected in the yolk in a position close to the blastomeres at the 1- to 4 cell stages. For DFC specific knockdown, injections were performed in the yolk close to the blastomeres at the 256- to 1 K-cell stage as described in [@bib64]. Names, sequences and amounts of MO injected in knockdowns and DFC specific knockdowns are provided in [Table 1](#table1){ref-type="table"}. In all experiments control embryos were injected with 8 ng of standard MO.

10.7554/eLife.45241.026

###### Name, sequence and amount of MO used in knockdown and in DFC targeted knockdown.

  MO name               Sequence                    References             Amounts injected for knockdown   Amounts injected for DFC targeted knockdown
  --------------------- --------------------------- ---------------------- -------------------------------- ---------------------------------------------
  Vgll4l MO1            TGTAGTGGAAATTAGTGACCGCCAT   This study             8 ng                             
  Vgll4l MOsp           TTGGGCTGTCCTGTGAAAAGATGAG   This study             6 ng                             
  Vgll4b MO1            ACAGGTCCATTTTGGTAAAAAGCAT   ([@bib45])             4 ng                             8 ng
  Vgll4b MO2            AATCGCAGAAAGAGCAGCTTCTCTT   This study             4 ng                             
  Yap MO1               CTCTTCTTTCTATCCAACAGAAACC   ([@bib31]; [@bib34])   6 ng                             
  Yap MOsp              AGCAACATTAACAACTCACTTTAGG   ([@bib56])             4 ng                             
  Taz MO1               CTGGAGAGGATTACCGCTCATGGTC   ([@bib30])                                              8 ng
  Taz MOsp1             TGTATGTGTTTCACACTCACCCAGG   This study             6 ng                             
  Taz MOsp2             ATGTGACTGCACAACAAACACAGAA   This study             6 ng                             
  Tead1a MO1            CATGGCAATGGATGTGATCTCAGAG   This study             8 ng                             
  Tead1a MO2            TGAGCCTGGAGAACTCAAGGCACAC   This study             8 ng                             
  Tead3a MO1            CGTCCATTCCGGTTTTGTCCATCCC   This study                                              2 ng
  Tead3a MOsp1          CAGCTTTCTGTTACTCACCATACAT   This study             8 ng                             
  Tead3a MOsp2          GGGTCTGAAATACTCACTCCTGAGA   This study             8 ng                             
  Dnmt3bb.1 MO1         TTATTTCTTCCTTCCTCATCCTGTC   ([@bib32]; [@bib55])   8 ng                             8 ng
  Dnmt3bb.1 MOsp        CTCTCATCTGAAAGAATAGCAGAGT   ([@bib28])             6 ng                             6 ng
  Dnmt3bb.2 MO1         CTCCGATCTTTACATCTGCCACCAT   ([@bib32]; [@bib55])   6 ng                             6 ng
  Dnmt3bb.2 MOsp        GCACCTGAAAAAGTGTAAACACCAT   This study             6 ng                             6 ng
  Mbd3a MO              CCACCTTTTCCTCTCCATGATTTTC   ([@bib32])             8 ng                             4 ng
  Mbd3b MO              TCGTTTTTCTCCATCTCGCATTCTC   This study             8 ng                             4 ng
  Standard control MO   CCTCTTACCTCAGTTACAATTTATA   Gene tools             8 ng                             8 ng

Antisense oligonucleotides (ASO) knockdowns {#s4-4}
-------------------------------------------

Two non overlapping 2\' O-Methyl RNA antisense oligonucleotides targeting the 5' end of Vgll4l coding sequence were synthesized by Integrated DNA Technologies.

Vgll4l 2'OMe ASO-1: mG\*mU\*mG\*mG\*mA\*A\*A\*T\*T\*A\*G\*T\*G\*A\*C\*mC\*mG\*mC\*mC\*mA

Vgll4l 2'OMe ASO-2 : mC\*mU\*mG\*mC\*mU\*C\*A\*T\*C\*C\*T\*G\*G\*T\*T\*mA\*mU\*mG\*mU\*mA mA,mU,mC,mG: 2'O-Methyl(2'OMe)-modified RNA nucleotides; \* phosphorothioate bond. ASO-1 and ASO-2 are respectively complementary to nucleotides 2--22 and 23--43 of the *vgll4l* open reading frame.

Knockdowns were performed as described in [@bib51] by injection of 75 ng of each ASO into WT embryos at the 1- to 2 cell stage.

Sense RNA synthesis and injection {#s4-5}
---------------------------------

PCR amplified fragments containing the complete open reading frame of Vgll4l, Vgll4b, Yap, Taz or Dnmt3bb.1 were cloned into the pCS2+ vector. For mRNA synthesis, constructs were linearized with NotI and transcribed using SP6 RNA polymerase using the mMESSAGE mMACHINE kit (Ambion). In vitro synthesized sense RNAs were injected either alone or in combination with MOs in rescue experiments. DFCs specific gain of function have been performed by injecting 0.4 µg of in vitro synthesized mRNA in the yolk of embryos at the 256--512 cell stages as described in [@bib22]; [@bib42].

Crispr/Cas9 mutagenesis {#s4-6}
-----------------------

Target sequences for CRISPR/Cas9 were identified using the optimized CRISPR Design -- MIT (<http://crispr.mit.edu/>). Complementary primers for the target sites were annealed and ligated into BSA1-cleaved pDR274 plasmid ([@bib33]) (plasmid \# 42250 from Keith Joung, obtained from Addgene). Plasmids for sgRNAs were linearized using Dra1 enzyme and sgRNAs synthesized with the Maxiscript-T7 kit from Ambion. As described in [@bib13] RNP complexes were formed by incubating 900 ng/µl of Cas9 protein (New England Biolabs) with 150 ng/µl of sgRNA in 300 mM KCl for 5 min at 37°C. The complexes were then injected into 1 cell stage embryos. Adult F0 fish were outcrossed to WT fish. Then, genomic DNA was extracted from fin clips of adult F1 individuals ([@bib44]). Targeted region was amplified by PCR and analyzed for INDELs using an heteroduplex mobility assay ([@bib49]). Sequence of oligonucleotides used is provided in [Supplementary file 4](#supp4){ref-type="supplementary-material"}. Position and sequence of mutants is provided in [Supplementary files 6](#supp6){ref-type="supplementary-material"}--[9](#supp9){ref-type="supplementary-material"}.

TALEN mutagenesis {#s4-7}
-----------------

TALEN sequences for mutagenesis of Dnmt3bb.1, Dnmt3bb.2 and Dnmt3ba were selected using Targeter 2.0 software ([@bib21]). TAL repeat assembly was achieved using the Golden Gate assembly method, and assembled repeats were integrated into the GoldyTALEN scaffold ([@bib8]; [@bib14]). Assembled vectors served as templates for in vitro mRNA transcription using the T3 mMessage mMachine kit (Ambion) according to manufacturer's instructions. 50--100 pg mRNA was injected into WT embryos at the one-cell stage. Position and sequences of mutants is provided in [Supplementary files 8](#supp8){ref-type="supplementary-material"} and [9](#supp9){ref-type="supplementary-material"}.

Immunohistochemistry and imaging {#s4-8}
--------------------------------

Embryos were fixed overnight at 4°C in 4% paraformaldehyde then washed 3 times for 20 min in a PBS medium containing 1% Triton X100 (PBS-1%Triton) for 20 min. Embryos were incubated for 1 hr in the blocking buffer (PBS-1%Triton, sheep serum 10%) then overnight at 4°C in a medium containing the primary antibody: anti-Acetylated Tubulin (Sigma-Aldrich T7451), anti Phospho Histone H3 (Ser10) (Cell Signaling, 9701) or anti Cleaved Caspase 3 (Asp175) (Cell Signaling, 9661) used at 1:400 dilution, anti Sox17 (Novus, NBP2-24568), anti Yap (Cell Signaling, 4912) used at 1:200 dilution and anti 5-methyl-cytosine (abcam, ab10805) used at 1:10,000 dilution in the blocking buffer. Embryos were then washed 3 × 20 min with PBS-1%Triton and incubated 2 hr at room temperature in a medium containing the secondary antibody: a goat anti-rabbit Alexa Fluor 488 (Thermofisher, A11008) or a goat anti-mouse Alexa Fluor 546 (Thermofisher, A11030) used at a 1:800 dilution in the blocking buffer, and 2% Hoechst 33342 (Sigma-Aldrich) to label the nuclei. After three final washes of 20 min in PBS-1%Triton, embryos were mounted in 2% low melting agarose. Representative images were acquired using a Leica TCS LSI confocal macroscope. Images were analyzed using Image J software.

Quantitative analysis of Kupffer's vesicle size, cilia length and number of DFCs {#s4-9}
--------------------------------------------------------------------------------

KV size, cilia length and DFCs were quantified as described in [@bib26]; [@bib27]. Embryos were observed in brightfield using a Leica macroscope and the area of the KV lumen was measured using the ImageJ software (NIH). For cilia, embryos immunostained with acetylated-tubulin antibodies were imaged using a Leica TCS LSI confocal macroscope and the length of cilia was measured using ImageJ software. The number of DFCs was determined using the *Tg(sox17:GFP)^S870^* by manually counting the number of Hoechst 33342 labeled nuclei of GFP+ DFCs in a Z-series of images collected using a Leica TCS LSI confocal macroscope.

For statistical analyses, P values were calculated with Graphpad prism eight software using two-tailed unpaired t-test. All raw data are available in [Figure 2---source data 1](#fig2sdata1){ref-type="supplementary-material"}, [Figure 3---source data 1](#fig3sdata1){ref-type="supplementary-material"} and [Figure 9---source data 1](#fig9sdata1){ref-type="supplementary-material"}.

Pharmacological treatments {#s4-10}
--------------------------

Verteporfin treatment: a 2 mg/ml stock solution of Verteporfin (SML0534, Sigma) was prepared in dimethylsulfoxide (DMSO). Embryos were incubated from the 1 cell stage to 24 hpf with verteporfin diluted in 0.3 x Danieau buffer at a final concentration of 2.5 µM.

RNA extraction, cDNA library preparation and RNA-Seq {#s4-11}
----------------------------------------------------

DFCs were dissected out in DMEM/F-12 medium (Gibco Dulbecco\'s Modified Eagle Medium: Nutrient Mixture F-12) from embryos of the Tg(sox17:GFP) line at the 90% epiboly stage injected at the 1 cell stage with 8 ng of standard MO (Control), 4 ng of Vgll4l MOsp or together with 4 ng of Yap MO1 and 4 ng of Taz MOsp1. Individual samples were transferred in a 0.5 ml Eppendorf tube with 2 µl of DMEM/F12. Total RNA was extracted and purified using SMART-Seq v4 Ultra Low Input RNA Kit for Sequencing from Clontech. Purified RNA samples were then reverse transcribed into cDNA and amplified. Libraries were constructed using a NEB DNA Ultra library construction kit (New England Biolabs), with standard TruSeq-type adapters. Libraries size and concentration were assessed using an Agilent 2100 Bioanalyzer. Libraries were multiplexed and 50 bp single-end were sequenced (Beijing Genomics Institute) on illumina Hiseq 2000 sequencer generating a minimum of 20 million reads per sample. Genome-wide transcriptome were produced from quadruplicate biological replicates.

Bioinformatics {#s4-12}
--------------

Bioinformatic analysis was performed by UVA bioinformatics core facility. Sequences alignment was done using STAR. Reads were mapped to GRCz10 Ensembl genes using the featureCounts software. DESeq2 Bioconductor package was used to normalize count data, estimate dispersion, and fit a negative binomial model for each gene. The Benjamini-Hochberg False Discovery Rate procedure was used to re-estimate the adjusted p-values for Ensembl gene IDs mapping to known genes. GO-term analysis was done in cytoscape 3.2.2 using the cluego plugin ([@bib9]). Heatmap was generated using heatmap.2 plugin in R.
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###### Transcriptome of DFCs at 80% epiboly in Control (Ctrl), Vgll4l and Yap/Taz loss-of-function.

10.7554/eLife.45241.028

###### Regulation of the expression by Vgll4l and Yap/Taz of zebrafish homologs of Yap direct target genes in mammals.

Table summarizing the variation of expression (fold change) of genes differentially expressed (normalized counts \> 1, llog2foldchangel ≥ 1, adjusted P value ≤ 0,05) between control and Vgll4l or Yap/Taz morphants for 143 zebrafish homologs of Yap direct target genes in mammals. Reference source for the set of Yap direct target genes: (1) ([@bib71]), (2) ([@bib67]), (3) ([@bib41])

10.7554/eLife.45241.029

###### Expression of genes known to be required for DFCs and/or KV development in control and in Vgll4l or Yap/Taz loss-of-function condition.

10.7554/eLife.45241.030

###### Expression of genes coding for proteins involved in ciliogenesis and known to be required for proper function of the LRO in control and in Vgll4l or Yap/Taz loss-of-function condition.

10.7554/eLife.45241.031

###### Sequence of primers used to generate sgRNAs and for screening Crispr/Cas9 mutants.

10.7554/eLife.45241.032

###### Position of MO, ASO target sequences and of mutations in *vgll4l*, *vgll4b*, *yap*, *taz*, *tead1a* and *tead3a*.

10.7554/eLife.45241.033

###### Sequences of mutations in *vgll4l*, *vgll4b*, *yap*, *taz*, *tead1a* and *tead3a*.

10.7554/eLife.45241.034

###### Position of MO target sequences and mutations in *dnmt3bb.1*, *dnmt3bb.2*, *dnmt3ba*, *mbd3a* and *mbd3b*.

10.7554/eLife.45241.035

###### Sequence of *dnmt3bb.1*, *dnmt3bb.2* and *dnmt3ba* mutants.

10.7554/eLife.45241.036

Data availability {#s7}
=================

RNA sequencing data that support the findings of this study have been deposited in the Gene Expression Omnibus (GEO) under accession code GSE119623 and are also provided in Supplementary file 1. All data generated or analysed during this study are included in the manuscript and supporting files. Source data for Figure 1, 2, 3, 9, Figure 1---figure supplement 2 and Figure 2---figure supplement 2 has been provided.

The following dataset was generated:

FillatreJThisseCThisseB2018RNA-seq of zebrafish embryo dorsal forerunner cells lacking Vestigial like 4 like (Vgll4l) or Yes associated protein 1 (Yap1)/ WW domain containing transcription regulator 1 (Wwtr1/Taz) activitiesNCBI Gene Expression OmnibusGSE119623

10.7554/eLife.45241.040

Decision letter

Vermot

Julien

Reviewing Editor

Institut de Génétique et de Biologie Moléculaire et Cellulaire

France

In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for sending your article entitled \"Transcription factors downstream of hippo signaling control the establishment of left-right asymmetry in zebrafish\" for peer review at *eLife*. Your article is being evaluated by Didier Stainier as the Senior Editor, a guest Reviewing Editor, and three reviewers.

All three reviewers were enthusiastic about many aspects of your manuscript but also asked for rather detailed changes that are likely to take considerable time. This includes improving several points of the study, in particular the part showing that VGLL4 acts in parallel of YAP/TAZ and clarification about the activity of YAP/TAZ during KV morphogenesis. The reviewers also felt that the gene list directly or indirectly regulated by hippo transcription factors provided did not help to understand better what is the function of hippo signaling in KV development.

*Reviewer \#1:*

Summary:

In the manuscript \"Transcription factors downstream of hippo signaling control the establishment of left-right asymmetry in zebrafish\", Fillatre et al., investigate whether transcriptional components of the Hippo pathway regulate the formation of the Left-Right Organizer. Using genetic knockdowns/knockouts and pharmacological manipulations, the authors report some interesting phenotypes that suggest important roles of VGLL4 and YAP/TAZ for the left-right organization in the developing zebrafish embryo. Especially, the role in cilia formation, as well as the potential role of VGLL4 in controlling epigenetic gene expression, are of interest. However, the paper is still preliminary and suffers from the reliance on just loss-of-function approaches, whose specificity have not been sufficiently validated. Another weak point is the correlative nature of most of the studies. As illustrated, it remains unclear if and how VGLL4 regulates YAP/TAZ signaling, and whether changes in this signaling module are directly linked to the formation of the Left-Right Organizer. Thus, the mechanistic aspect of this paper is weak.

Essential revisions:

1\) The authors use genetic and pharmacological approaches that interfere with YAP/TAZ-TEAD- and VGLL-dependent transcription in all cells and tissues. Given the essentiality of this transcriptional mechanism for general growth and development, one wonders whether the laterality defects are secondary to changes in tissue morphogenesis.

2\) The authors do not provide direct evidence that VGLL4 interferes with YAP/TAZ-TEAD function. Thus, it remains unclear whether VGLL4 signals through its canonical pathway or via alternative transcription factors. What happens to prototypical YAP/TAZ target genes in LRO progenitors sorted form Tg(sox17:GFP)S870 cells? This should give clues on how VGLL4 functions. As well what about the expression of YAP/TAZ and their targets in YAP/TAZ knockdown/knockout cells?

3\) It is not clear from the data shown whether YAP/TAZ and VGLL4 have a specific role in the formation of the Kupffer vesicle (KV) or whether their loss has general effects on dorsal forerunner cell (DFC) proliferation and viability. Effects on the latter might explain the vast changes in gene expression observed in the different mutants. Are DFC-specific genes direct YAP/TAZ target genes that are co-regulated by VGLL4?

4\) The authors show that components of Hippo signaling are necessary for KV formation but what about sufficiency? Does activation or nuclear localization of YAP or TAZ drive DFC expansion?

*Reviewer \#2:*

In this manuscript, Fillatre et al., present an interesting study of the effects of Hippo signalling pathway on the establishment of left-right asymmetry in zebrafish. Using different genetic tools, the authors show that transcription factors and cofactors that are downstream effectors of the Hippo pathway are necessary for the formation of LRO. They also perform a transcriptomic analysis on DFCs of Vgll4l and yap/taz morphants to show that these factors affect a number of genes previously shown to be expressed in DFCs, a panel of signalling pathways and finally different readers and writers that affect the epigenetic landscape of these cells. All in all, the study is interesting and thorough and the experiments performed were carefully designed and executed. One major problem is that this study does not permit the assessment of the genes that are directly regulated by these transcription factors and co-factors.

Of course, it is difficult to perform experiments such as chromatin immunoprecipitation in zebrafish, but the authors could provide some more insights regarding this aspect:

1\) The authors could perform chromatin accessibility assays and check for motifs of the Hippo pathway. This experiment is doable with low cell numbers and could give a hint of the genes that are directly regulated by the Hippo pathway.

2\) The authors perform their transcriptomic analysis on morphants. In this way the targeted gene is affected in the whole animal from the beginning of development and this could lead to many secondary effects. Since the authors have performed some of their genetic experiments on DFC specific knockdowns, maybe they can check by qPCR whether deregulated genes identified in their transcriptomic analysis are also deregulated in these tissue specific knockdown animals. In this way they could identify a tighter list of genes that are regulated by Hippo signalling transcription factors.

3\) The authors performed a partial rescue experiment by expressing dnmt3bb.1. This rescue also provides an opportunity to check by transcriptomic analysis what is the expression profile during this rescue and provide a list of genes that are necessary for DFC formation.

*Reviewer \#3:*

There are two major concerns with the present study:

1\) It is not sufficiently clear to what degree the different transcriptional effectors of the Hippo signaling pathway differ in their function during KV development. Wouldn\'t one expect, for instance, that l-o-f of yap/taz has the opposite effect than that of vgll? Along the same vein, it would be important to see how the subcellular/nuclear localization of the analyzed transcription factors is dynamically regulated in DFCs and/or KV cells. For YAP and TAZ, for instance, there are previously characterized antibodies available that could be used. This might provide important additional insight into their expected functions in this process.

2\) The authors identify a very large number (8-9k) of genes, the expression which is controlled by vgll and/or yap/taz. That said, it is perhaps not entirely surprising to find within those targets genes previously involved in KV development. It is, however, quite worrying to see that a large fraction (10/24) of the genes the authors have shown to be strongly regulated by in situ hybridization, were not amongst those targets. In the light of this, it is not clear how meaningful the transcriptomic approach has been and what can be learned from it.

10.7554/eLife.45241.041

Author response

Reviewer \#1:

> Summary:
>
> In the manuscript \"Transcription factors downstream of hippo signaling control the establishment of left-right asymmetry in zebrafish\", Fillatre et al., investigate whether transcriptional components of the Hippo pathway regulate the formation of the Left-Right Organizer. Using genetic knockdowns/knockouts and pharmacological manipulations, the authors report some interesting phenotypes that suggest important roles of VGLL4 and YAP/TAZ for the left-right organization in the developing zebrafish embryo. Especially, the role in cilia formation, as well as the potential role of VGLL4 in controlling epigenetic gene expression, are of interest. However, the paper is still preliminary and suffers from the reliance on just loss-of-function approaches, whose specificity have not been sufficiently validated.

This is correct that our analysis is mainly based on loss of function experiments. They demonstrate the requirement for each of the 6 genes analyzed in the formation of the zebrafish left-right organizer (LRO). In particular we found that the activity of each of these 6 transcription factors and cofactors are needed in DFCs for the formation and function of the Kupffer's vesicle and for the assembly and function of motile cilia that are essential to the activity of the LRO. Therefore, loss-of-function approaches are particularly appropriate to demonstrate the requirement of these transcription factors and cofactors to the proper differentiation of the LRO progenitors into a functional Kupffer's vesicle.

We are not sure we understand the reviewer's comments about the lack of validation of these loss-of-function experiments. In this study, we used a combination of strategies to generate loss-of-function conditions including: knockdowns, pharmacological drug treatments and genetic approaches to establish the requirement of each of the 6 transcription factors and cofactors: Vgll4l, Vgll4b, Yap, Taz, Tead1a and Tead3a, in the formation of the zebrafish LR organizer (e.g., Figure 1, Figure 1---figure supplement 2).

Results from knockdown experiments have been validated by:

1\) Using different, non-overlapping, morpholinos (MO) or antisense oligonucleotides (ASO) and showing they result in the same loss of function phenotype.

2\) By targeting either translation or splicing and obtaining the defects.

3\) By rescuing knockdown phenotypes through injections of morpholinos insensitive in vitro synthesized mRNAs.

4\) For Yap we also used a specific pharmacological drug and observed the same phenotypes as those observed for MO knockdown of Yap function on the formation of the LRO.

5\) We confirmed data obtained in knockdown experiments by generating Crispr-Cas9 mutants that display identical phenotypic defects. This is shown in a new figure (Figure 1---figure supplement 3). In this figure we also show that the global morphology of homozygous mutant embryos is not affected indicating that the effect on DFCs/KV is not a secondary consequence of a global defect of embryo development.

In addition, in the revised version of our manuscript we provide phenotypic analysis of KV defects in homozygous mutant embryos (Figure 2---figure supplement 1).

6\) In addition to loss of function studies, we have performed DFC specific gain of function of Yap presented in (Figure 2---figure supplement 2) that shows that as known for Yap function in other vertebrates, increase of its activity results in an increased size of the organ associated with an increased number of cells.

7\) Finally, we took advantage of a unique property of DFCs: these cells are the last embryonic cells to keep cytoplasmic connections with the yolk syncytial layer. Therefore, they can be specifically targeted by MO injection into the yolk after the other embryonic cells have lost their connection to the yolk syncytial layer. This allows DFCs specific knockdown (as well as DFC specific gain of function). This technique has been established by Amack and Yost, 2004 and is widely used by the community working on DFCs and Kupffer's vesicle. A detailed protocol has been published in Wang, Yost and Amack, 2013. Using this approach, we have been able to examine the tissue specific effect of the loss of function of each gene in DFCs without affecting other embryonic cells.

Altogether, all the experimental approaches listed above, the controls we performed and the identity of phenotype on the formation of the LRO we observed in each experimental condition provide a full validation that lack of any of the 6 genes analyzed results in disruption of the differentiation of DFCs into the functional zebrafish LRO.

> Another weak point is the correlative nature of most of the studies. As illustrated, it remains unclear if and how VGLL4 regulates YAP/TAZ signaling, and whether changes in this signaling module are directly linked to the formation of the Left-Right Organizer. Thus, the mechanistic aspect of this paper is weak.

Our comments about the second major criticism of reviewer 1 (about the regulation of Yap/Taz by Vgll4) is detailed below in our responses to his/her different major comments.

> Essential revisions:
>
> 1\) The authors use genetic and pharmacological approaches that interfere with YAP/TAZ-TEAD- and VGLL-dependent transcription in all cells and tissues. Given the essentiality of this transcriptional mechanism for general growth and development, one wonders whether the laterality defects are secondary to changes in tissue morphogenesis.

We understand the concern of reviewer 1 about a possible secondary effect of Yap/TazTEAD and Vgll4 on DFCs due to general changes in tissue morphogenesis. However, two lines of evidence show that impact of the lack of any of the transcription factors and cofactors on KV formation is not a secondary consequence of a global change in growth and development of the embryo:

1\) Despite of their essential role in controlling general growth and development, individual mutants of Yap1, Taz, Vgll4l, Vgll4b and Tead3a display a normal morphology at late embryonic stages and are able to give rise to fertile adults (Figure 1---figure supplement 3). This observation has been previously reported for Yap and for Taz (Miesfield et al., 2015). Therefore, we observe strong defects in the formation of the LRO (and in consequence on the LR asymmetry of the embryo) in both mutants and morphants while the global morphology, growth and development of the embryos is unaffected. This shows that the lack of function of each of these different genes is not likely to affect the formation of the Kupffer's vesicle as a secondary consequence of a global change in embryonic development and growth.

We provide two additional figures to illustrate this point:

1\) in Figure1---figure supplement 3 we show that the homozygous mutant embryos at two days of development (a time where the LR asymmetry is already established) do not have major developmental defects while (2) their Kupffer's vesicle (observed at early somitogensis) is strongly affected (Figure 2---figure supplement 1).

2\) As stated above, we found the same strong defects in LRO formation and in the laterality of the embryo in DFCs specific knockdown experiments (as exemplified in Figure1---figure supplement 2). In these conditions, defects observed in formation of the Kupffer's vesicle result only from specific knockdowns of each gene in the LRO progenitors. Therefore, the phenotype we observe cannot be an indirect secondary consequence of an early global effect on the embryonic development.

> 2\) The authors do not provide direct evidence that VGLL4 interferes with YAP/TAZ-TEAD function. Thus, it remains unclear whether VGLL4 signals through its canonical pathway or via alternative transcription factors.

This is correct, we do not provide evidence of interference of Vgll4 with Yap/Taz-TEAD because we didn't find any evidence for such interference in DFCs during their differentiation into the Kupffer's vesicle. Based on published data we initially hypothesized that Vgll4s and Yap/Taz may have opposite effects and that Vgll4s will interfere with Yap/Taz as it has been shown in other model systems. Our observations however do not support this mechanism in the DFCs during the formation of the LRO. Here are the pieces of evidence:

1\) The Kupffer's vesicle phenotype is very similar between Vgll4s and Yap/Taz loss of function, while an antagonistic effect of Vgll4s and Yap/Taz should have generated different/opposite phenotypes.

2\) The Kupffer's vesicle phenotype of *tead1a* and *tead3a* is also similar to both Vgll4s and Yap/Taz loss of function.

3\) Transcriptome data show that for genes regulated by both Vgll4l and Yap/Taz, a vast majority (84%) is regulated similarly by Vgll4l and Yap/Taz while only 16% are regulated in opposite way (see Venn diagram Figure 5B).

> What happens to prototypical YAP/TAZ target genes in LRO progenitors sorted form Tg(sox17:GFP)S870 cells? This should give clues on how VGLL4 functions.

We analyzed the impact of Yap/Taz and Vgll4 loss of function on the transcription of Yap direct target genes identified in other systems.

We performed a compilation of 380 mammalian genes (human and rat) from 3 publications: Zanconato et al., 2015; Wang et al., 2018; Lin, Z et al., 2015.

In the zebrafish genome (GRCz10) we found 318 homologues for these 380 Yap direct target genes. Looking at our transcriptome data we found that 143 out of the 318 homologues were expressed in the DFCs (normalized counts ≥1 in any of these conditions: control, vgll4l Yap, Taz, Tead1a and Tead3a, in the formation of the zebrafish LR organizer (e.g.: Figure 1, Figure 1---figure supplement 2). (llog2foldchangel≥1 and a justed P value ≤ 0.05).

This set of 143 genes correspond to the zebrafish homologues of direct targets of Yap (likely to be also direct targets in zebrafish) whose expression is regulated by both Yap/Taz and Vgll4l in the DFCs. If Vgll4l acts as an antagonist of Yap/Taz by competing for binding of Teads we should expect to see opposite regulation of these genes in Vgll4l and Yap/Taz loss of function.

This is not what we observe: we found that 118/143 genes (82.5%) were regulated similarly in both conditions (61 downregulated and 57 upregulated in both Vgll4l and Yap/Taz loss of function) and only 25/143 (17.5%) were regulated in opposite ways. This strongly supports that Vgll4l and Yap/Taz do not act antagonistically during the process of LRO formation.

We now discuss these data in the text and provide a table (Supplementary file 2) with the transcriptome data for these 143 genes.

> As well what about the expression of YAP/TAZ and their targets in YAP/TAZ knockdown/knockout cells?

The expression of Yap/Taz and their targets in knockdown cells is provided in the transcriptome (Supplement file 1). The expression of 143 direct targets of Yap are provided together with Vgll4l data in Supplement file 2.

For the expression of the main Yap target genes reported so far (mainly in human cancer cells), a list is provided below: with the number of normalized counts for each gene in control and in Yap/Taz morphant as well as Log2foldchange for expression of Yap direct genes and the references for studies identifying these genes as direct Yap targets.

The analysis of the expression of the zebrafish homologue of 39 Yap direct targets identified in mammals (pulled out from 10 different studies) reveals that 15 are downregulated in Yap/Taz morphants indicating that Yap/Taz act as activators of these genes; 7 genes are upregulated indicating that Yap/Taz act as repressors of their expression; finally 17 genes are not expressed and/or not regulated by Yap/Taz in DFCs.

While *ddit4* has been shown to be repressed by Yap/Taz in mammal (Kim et al., 2015), all the other Yap targets have been described to be activated.

We found that only 16 genes (15 activated genes plus *ddit4*) in this list of 39 genes are regulated similarly in KV progenitors and in mammalian cells.

These differences in gene regulation (essentially between cancer and embryonic cells during organogenesis) indicate that Yap controls different sets of genes in zebrafish during organogenesis and in human cancer cells. Because this observation does not provide any information about the role of Yap in the formation of the LRO we decided not to add the table presented in [Author response table 1](#resptable1){ref-type="table"} in the manuscript.

  ---- --------------------------------------------------- ---------- ------------- ---------------- --------- --------------------------------------
       **Gene**                                            **Ctrl**   **Yap/Taz**   **Yap/Taz FC**   **ref**   
  1    igfbp3                                              278        **0**         **-9.8**         6         **activated by Yap/Taz in DFCs**
  2    F3                                                  127        **0**         **-9.4**         6         
  3    crim1                                               60         **0**         **-8.3**         6         
  4    Diaph3                                              57         **0**         **-7.6**         9         
  5    rbms3                                               47         **0**         **-7.4**         6         
  6    Cdc42ep3                                            21         **0**         **-6.9**         9         
  7    ccdc80                                              27         **0**         **-6.6**         6         
  8    nuak2                                               251        **16**        **-3.9**         6         
  9    ptgs2a                                              110        **11**        **-3.2**         4         
  10   [anln](http://europepmc.org/articles/PMC5795783/)   908        **182**       **-2.3**         9         
  11   gpatch4                                             262        **73**        **-1.8**         10        
  12   lmnb2                                               3219       **1385**      **-1.2**         10        
  13   amotl2a                                             912        **394**       **-1.2**         6         
  14   dock5                                               11         **4**         **-1.2**         6         
  15   myof                                                1037       **428**       **-1.2**         6         
  1    ddit4                                               1235       **2830**      **1.1**          8         **repressed by Yap/Taz in DFCs**
  2    txn                                                 767        **4574**      **2.5**          5         
  3    Thbs1                                               2          **17**        **2.8**          9         
  4    ankrd1a                                             0          **59**        **6.8**          1         
  5    ankrd1a                                             0          **59**        **6.8**          6         
  6    gadd45ab                                            1          **202**       **7**            6         
  7    Plaua                                               0          **77**        **7.3**          7         
  8    Serpine1                                            0          201           **8.6**          9         
  1    ankrd1b                                             0          0             NS               1         **not regulated by Yap/Taz in DFCs**
  2    cat                                                 106        88            NS               2         
  3    ptgs2b                                              0          0             NS               4         
  4    wsb2                                                0          0             NS               10        
  5    cyr61                                               0          0             NS               6         
  6    ctgfa                                               0          0             NS               6         
  7    ctgfb                                               0          0             NS               6         
  8    amotl2b                                             21         12            NS               6         
  9    ankrd1b                                             0          0             NS               6         
  10   last2                                               157        267           NS               6         
  11   gadd45aa                                            0          0             NS               6         
  12   tgfb2                                               0          0             NS               6         
  13   nt5e                                                0          0             NS               6         
  14   foxf2                                               0          0             NS               6         
  15   asap1                                               0          0             NS               6         
  16   Plaub                                               0          0             NS               7         
  17   Wtip                                                0          1             NS               9         
  ---- --------------------------------------------------- ---------- ------------- ---------------- --------- --------------------------------------

> 3\) It is not clear from the data shown whether YAP/TAZ and VGLL4 have a specific role in the formation of the Kupffer vesicle (KV) or whether their loss has general effects on dorsal forerunner cell (DFC) proliferation and viability. Effects on the latter might explain the vast changes in gene expression observed in the different mutants.

There is an effect on proliferation and viability of DFCs but most of these cells do not die. A vast majority of DFCs used for the transcriptome analysis were not apoptotic (in average 1 or 2 apoptotic cells out of \~25-38 cells present in DFC clusters analyzed by RNA-seq). In addition, we found that lack of Vgll4l and Yap/Taz functions affects the differentiation of these cells. In particular they strongly affect genes involved in cilia organization and cilia motility. Yap has been reported to be involved in formation of non-motile cilia during zebrafish kidney development (He et al., 2015). This suggests that in addition to its well-known control of organ growth, Yap plays also a specific role in ciliogenesis. Our observation of the strong disruption of motile ciliogenesis in Yap/Taz morphants (Figure 3) supports the specific role of these TcoFs in the regulation of ciliogenesis.

Finally, in addition of a large set of genes regulated by both Yap/Taz and Vgll4l we found genes regulated only by Yap/Taz or only by Vgll4l. For example, 759 genes are downregulated only in Yap/Taz morphants while 1209 other genes are downregulated only in Vgll4l loss of function (Figure 5B). If the effect of Yap/Taz and Vgll4l on the formation of the LRO was simply resulting from a global disruption of cell physiology when their viability is impaired the transcriptome of DFCs in Yap/Taz and Vgll4l morphants would appear more similar. In particular, GO term analysis (Figure 5C) shows that both Yap/Taz and Vgll4l affect cilium movement, cilium organization and epithelium development but that Yap/Taz regulates mitotic cell cycle process (in agreement with the known function of these transcription cofactors) while Vgll4l regulates genes involved in covalent chromatin modification. Therefore, while the impact of Yap/Taz and Vgll4l on the DFC transcriptome is wide, their effects are specific, ruling out that the change in gene expression observed in the different morphants is simply a secondary consequence of an impairment in cell viability.

> Are DFC-specific genes direct YAP/TAZ target genes that are co-regulated by VGLL4?

Direct Yap/Taz targets in DFCs are unknown. Due to the very small number of DFCs (50 cells in WT) we cannot expect to be able to perform ChIP-seq experiments comparable to the quality published for human cells in culture (with millions of cells used).

As we proposed we performed ChIP-seq to try to characterize direct target genes for Vgll4l and Yap. For this experiment we used cells of the whole embryo isolated at late gastrula stage after injection of in the egg of mRNAs coding an Active-motif tagged versions of Yap or Vgll4l. Despite several attempts with 300 embryos injected per condition the amount of DNA was very low and as a result the number of specific ChIP-seq peaks was low as well. The final number of binding sites identified was too small to allow a statistical analysis of the regulation of Yap by Vgll4l on their direct target genes. Even with a good number of peaks, the result would have only been indicative as the analysis was done on the whole embryo and not on DFCs (which represent only 1% of the total number of cells at midgastrula stage).

> 4\) The authors show that components of Hippo signaling are necessary for KV formation but what about sufficiency? Does activation or nuclear localization of YAP or TAZ drive DFC expansion?

Neither Vgll4 nor Yap/Taz are sufficient to induce formation of the LRO. As we stated in the text; "in situ hybridization for sox17, an early DFC marker, we found that DFC clusters are present at early gastrula stage for every Hippo TFs/TcoFs mutant/morphant tested" and the number of DFCs at early gastrula stage (Figure 2F) is the same for both WT and morphant embryos". These TFs and TcoFs are not involved in the specification of the KV progenitors but are required at gastrula stage during the process of their differentiation into the KV.

The KV progenitors, the DFCs, are specified at late blastula stage in response to Nodal signaling. Therefore, while constitutively activated Activin receptor I (Acvr1b, the Nodal receptor) can induce DFCs at the animal pole of a zebrafish blastula (Compagnon et al., 2014) gain of functions of Taz, Yap or of a constitutive version of Yap (Yap5SA) are not sufficient to induce formation of ectopic DFCs. Of course, gain of function of Yap protein (known to stimulate proliferation) by injection of in vitro synthesized Yap mRNA in a DFC specific manner (that is after other cells of the embryo lose their cytoplasmic bridges with the yolk syncytial layer) results in an increase of the Kupffer's vesicle size associated with an increased number of cells in the enlarged Kupffer's vesicle. This experiment has been completed and the results are presented in Figure 2---figure supplement 2.

Reviewer \#2:

> \[...\] One major problem is that this study does not permit the assessment of the genes that are directly regulated by these transcription factors and co-factors.
>
> Of course, it is difficult to perform experiments such as chromatin immunoprecipitation in zebrafish, but the authors could provide some more insights regarding this aspect:
>
> 1\) The authors could perform chromatin accessibility assays and check for motifs of the Hippo pathway. This experiment is doable with low cell numbers and could give a hint of the genes that are directly regulated by the Hippo pathway.

We agree that ATAC-seq may be doable with a reasonable number of cells. Performing this experiment on DFCs will show the open chromatin sites (we can anticipate a very large number). Then we will have to check for possible TEAD1a or TEAD3a motifs in open chromatin domains. TEAD binding motif has not been characterized using zebrafish proteins and we will have to use vertebrate TEAD consensus sequences. Based on their frequency on the genome sequence we anticipate to have a quite large number of candidates.

As an alternative to ATAC-seq we proposed to perform ChIP-seq to try to characterize direct target genes for Vgll4l and Yap. Because of the small number of DFCs, for this experiment we used cells of the whole embryo isolated at late gastrula stage after injection of in the egg of mRNAs coding an Active-motif tagged versions of Yap or Vgll4l. Despite several attempts with 300 embryos injected per condition the amount of DNA was very low and as a result the number of specific ChIP-seq peaks was low as well. The final number of binding sites identified was too small to allow a statistical analysis of the regulation of Yap by Vgll4l on their direct target genes. Even with a good number of peaks, the result would have only been indicative as the analysis was done on the whole embryo and not on DFC cells (which represent only 1% of the total number of cells at midgastrula stage).

> 2\) The authors perform their transcriptomic analysis on morphants. In this way the targeted gene is affected in the whole animal from the beginning of development and this could lead to many secondary effects. Since the authors have performed some of their genetic experiments on DFC specific knockdowns, maybe they can check by qPCR whether deregulated genes identified in their transcriptomic analysis are also deregulated in these tissue specific knockdown animals. In this way they could identify a tighter list of genes that are regulated by Hippo signalling transcription factors.

We performed in situ hybridization on DFC specific knockdowns for some of the DFC genes (Figure 4) we found downregulated in global knockdowns. Results are presented in Figure 4---figure supplement 1. For all analyzed genes we observed the same reduction of expression in global knockdowns and in DFC specific knockdowns. In addition, we should mention that while global knockdowns affect the activity of the different TFs and TcoFs in the whole animal, we didn't observe any effect on the morphology of the embryo. This is shown in Figure1---figure supplement 3: homozygous mutant embryos do not display morphological defects (and most of them reach adulthood) while their laterality is strongly affected. Because other tissues and organs are formed normally and are fully functional, this strongly suggests that the effect observed for the loss of function of these TFs and TcoFs on the differentiation of the progenitors of the LRO is not the secondary consequence of an earlier broad effect of their loss of function on the development of the embryo.

> 3\) The authors performed a partial rescue experiment by expressing dnmt3bb.1. This rescue also provides an opportunity to check by transcriptomic analysis what is the expression profile during this rescue and provide a list of genes that are necessary for DFC formation.

We agree with reviewer 2 about the interest of this analysis. We are planning to perform in the future an extensive analysis of the impact of readers and writers of methylation marks on the transcriptome of DFCs but we think this interesting question deserves a full study, which is beyond the scope of the current manuscript.

Reviewer \#3:

> There are two major concerns with the present study:
>
> 1\) It is not sufficiently clear to what degree the different transcriptional effectors of the Hippo signaling pathway differ in their function during KV development. Wouldn\'t one expect, for instance, that l-o-f of yap/taz has the opposite effect than that of vgll?

An opposite effect of Yap/Taz and Vgll4l loss of function is what we initially expected, based on the current model of interaction between these TcoFs in control of organs growth or in a cancer cells model system. However, our study of the impact of the lack of these genes function on the transcriptome of the DFCs supports that this is not the case during the formation of the LRO:

Loss of function phenotypes (mutant, morphant, drug, antisense oligonucleotides) are similar for all genes. Most of our data support that Yap/Taz and Vgll4 have a similar role in the regulation of the number of DFCs at the end of gastrulation and in the formation of the ciliated epithelium of the LRO.

Most of differentially expressed genes identified in our transcriptome analysis are regulated similarly by Vgll4l and Yap/Taz and this is also true for the zebrafish homologues of direct Yap targets in mammals.

> Along the same vein, it would be important to see how the subcellular/nuclear localization of the analyzed transcription factors is dynamically regulated in DFCs and/or KV cells. For YAP and TAZ, for instance, there are previously characterized antibodies available that could be used. This might provide important additional insight into their expected functions in this process.

An opposite effect of Yap/Taz and Vgll4l loss of function is what we initially expected, based on the current model of interaction between these TcoFs in control of organs growth or in a cancer cells model system. However, our study of the impact of the lack of these genes function on the transcriptome of the DFCs supports that this is not the case during the formation of the LRO:

Loss of function phenotypes (mutant, morphant, drug, antisense oligonucleotides) are similar for all genes. Most of our data support that Yap/Taz and Vgll4 have a similar role in the regulation of the number of DFCs at the end of gastrulation and in the formation of the ciliated epithelium of the LRO.

Most of differentially expressed genes identified in our transcriptome analysis are regulated similarly by Vgll4l and Yap/Taz and this is also true for the zebrafish homologues of direct Yap targets in mammals.

> 2\) The authors identify a very large number (8-9k) of genes, the expression which is controlled by vgll and/or yap/taz. That said, it is perhaps not entirely surprising to find within those targets genes previously involved in KV development. It is, however, quite worrying to see that a large fraction (10/24) of the genes the authors have shown to be strongly regulated by in situ hybridization, were not amongst those targets. In the light of this, it is not clear how meaningful the transcriptomic approach has been and what can be learned from it.

An opposite effect of Yap/Taz and Vgll4l loss of function is what we initially expected, based on the current model of interaction between these TcoFs in control of organs growth or in a cancer cells model system. However, our study of the impact of the lack of these genes function on the transcriptome of the DFCs supports that this is not the case during the formation of the LRO:

Loss of function phenotypes (mutant, morphant, drug, antisense oligonucleotides) are similar for all genes. Most of our data support that Yap/Taz and Vgll4 have a similar role in the regulation of the number of DFCs at the end of gastrulation and in the formation of the ciliated epithelium of the LRO.

Most of differentially expressed genes identified in our transcriptome analysis are regulated similarly by Vgll4l and Yap/Taz and this is also true for the zebrafish homologues of direct Yap targets in mammals.
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